Novo Nordisk also announced plans to establish a new $800 million production facility in Denmark for tableting and packaging of oral products. That investment will create an estimated 100 new jobs.

Since the 1990s, Novo Nordisk has operated a facility in Clayton, where it makes injectable finished products like insulin pens to treat diabetes. In the past few years however, the company has ...

The Danish drugmaker Novo Nordisk is the largest private employer in fast-growing Johnston County. It opened its first Clayton facility in 1993 where it makes injectable finished products (IFPs ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...

Weight loss leader Novo Nordisk has had a poor performance at the stock markets year-to-date [YTD] even as the healthcare sector is among the least impacted ones. The key reason for this is ...

The popularity of Novo Nordisk's Ozempic and Wegovy has attracted competitors and created supply constraints. Novo Nordisk's next-generation weight loss drug disappointed investors in Phase III ...

U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral weight-loss drug news and BMO cut its rating for the Danish drug developer ...

https://www.tipranks.com/news/the-fly/novo-nordisk-warns-of-counterfeit-ozempic-injections Novo Nordisk (NVO) said it has become aware of several hundred units of ...

Novo Nordisk (NVO) said it has become aware of several hundred units of Ozempic injection outside the Novo Nordisk authorized supply chain in the U.S. The US Food and Drug Administration has also ...